Jeddah Health Cluster Two Signs Cooperation Agreement with Jamjoom Pharma to Enhance Healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies specializing in the pharmaceutical industry. This partnership aims to enhance health awareness and develop human capabilities within the medical sector in the Kingdom of Saudi Arabia.
This step comes within the framework of the cluster's efforts to support the Kingdom's Vision 2030, which places the development of the health sector among its top priorities. Through this collaboration, both parties seek to exchange expertise and scientific knowledge to improve the quality of services provided to patients in the Jeddah region.
The agreement includes organizing specialized training programs for medical staff, in addition to launching awareness campaigns aimed at educating the community about best health practices. Both parties will also work to support innovation in the pharmaceutical field and provide advanced therapeutic solutions that meet the needs of the population.
This initiative is part of a series of partnerships that Jeddah Health Cluster Two seeks to establish with the private sector, with the aim of integrating roles between government institutions and national companies. It is expected that these efforts will contribute to increasing the efficiency of the health system and enhancing its sustainability in the near future.